This white paper makes the practical case for tissue banks and tissue establishments to transition from paper-based record keeping and spreadsheets to purpose-built electronic traceability systems. It examines the risks inherent in manual methods, the operational and regulatory benefits of electronic systems, the common barriers to adoption, and the key factors that determine whether a transition succeeds or fails.
Many tissue banks and tissue establishments across the United Kingdom still rely, to some degree, on paper-based methods for tracking their samples and maintaining traceability records. Laboratory notebooks, printed logbooks, paper requisition forms, and Microsoft Excel spreadsheets remain part of daily operations in a significant number of organisations — particularly those with smaller teams, limited IT budgets, or long-established working practices.
There is nothing inherently wrong with paper. It is familiar, requires no software licence, and does not crash. However, as regulatory expectations increase, sample volumes grow, and the consequences of traceability failures become more visible, the limitations of paper-based systems are becoming harder to justify. The Human Tissue Authority (HTA) expects licensed establishments to maintain comprehensive, auditable traceability records for a minimum of 30 years. Achieving this with paper alone is technically possible but practically very difficult — and the risks of failure are substantial.
This paper is intended for tissue bank managers, quality officers, and laboratory leads who are considering or evaluating a move to an electronic system. It sets out the arguments, addresses common concerns, and provides practical guidance based on the experiences of tissue establishments that have already made the transition.
Paper-based systems present a number of well-documented risks that are particularly acute in the context of regulated tissue handling.
Data loss and degradation. Paper records are vulnerable to physical damage — fire, flood, accidental disposal, and simple wear and tear. Over a 30-year retention period, the probability of some loss or degradation is significant. Even well-maintained paper archives require dedicated storage space, environmental controls, and periodic checks to ensure legibility.
Transcription errors. Manual data entry — whether writing into a logbook or typing into a spreadsheet — introduces the risk of transcription errors. A transposed digit in a sample identifier, a misread handwritten entry, or a copy-paste error in a spreadsheet can result in a sample being attributed to the wrong donor, stored in the wrong location, or distributed to the wrong recipient. In a tissue bank handling hundreds or thousands of samples, even a small error rate has cumulative consequences.
No native audit trail. Paper records do not automatically capture who made an entry, when it was made, or whether it has been subsequently altered. While witnessed signatures and controlled notebooks can provide some assurance, they do not offer the tamper-evident, timestamped audit trail that electronic systems provide — and that the HTA increasingly expects to see.
Slow retrieval and lookback. In the event of a serious adverse event or reaction, the establishment must be able to trace all tissues and cells connected to a particular donor or recipient rapidly. With paper records, this may require searching through filing cabinets, cross-referencing multiple logbooks, and manually reconstructing the chain of custody — a process that can take hours or days rather than the minutes that an electronic system requires.
Spreadsheet-specific risks. Spreadsheets such as Microsoft Excel present their own set of problems. They are prone to accidental deletion or overwriting of data, formula errors that propagate silently across cells, and version-control issues when multiple copies are in circulation. They also lack the access control, audit trail, and validation features that regulated environments require. A well-known 2013 analysis of a JPMorgan Chase trading loss attributed, in part, to a spreadsheet error that went undetected — a reminder that even sophisticated organisations can be caught out by the limitations of spreadsheets used for critical data.
In practice, tissue establishments typically consider moving to an electronic system in response to one or more of the following drivers.
HTA inspection findings. A common trigger is an HTA inspection that identifies shortfalls or areas for improvement related to traceability, record keeping, or audit trails. Inspectors may note that the establishment cannot demonstrate a complete chain of custody, that records are difficult to retrieve, or that the audit trail is inadequate. These findings create direct pressure to improve the traceability system.
Growth in sample volume. As the number of samples managed by a tissue bank grows — whether through new research projects, additional donors, or expanded clinical activity — paper-based systems become increasingly unwieldy. What worked for 200 samples may be entirely impractical for 2,000 or 20,000.
Multi-site operations. When a tissue establishment operates across multiple buildings or sites, maintaining a consistent and accessible paper-based inventory becomes extremely difficult. Electronic systems allow all sites to access the same central database, with real-time visibility of sample locations and status.
Staff turnover. Paper-based systems are often highly dependent on the knowledge and practices of specific individuals. When those individuals leave, the institutional knowledge of how the system works — where records are kept, what abbreviations mean, how to find a particular sample — can leave with them. An electronic system captures this knowledge in a structured, accessible format.
Preparation for accreditation or funding applications. Grant funding bodies, accreditation schemes, and collaborative research networks increasingly require evidence of robust sample management and traceability as a condition of participation. An electronic system makes it straightforward to produce the documentation and reports required.
Tissue establishments that have transitioned to electronic traceability systems consistently report a range of practical benefits.
Time savings. Tasks that previously required manual searching, cross-referencing, and report compilation can be performed in a fraction of the time. Finding a specific sample, generating a traceability report for an HTA inspection, or producing an inventory summary for a management meeting takes minutes rather than hours.
Reduced errors. Barcode scanning at each stage of the tissue lifecycle eliminates the majority of transcription errors. The system validates inputs in real time, flagging inconsistencies before they become embedded in the records.
Improved compliance posture. With a complete, tamper-evident audit trail and the ability to demonstrate full chain of custody on demand, establishments are significantly better prepared for HTA inspections. Several organisations report that their inspection experience has improved markedly since implementing an electronic system.
Better visibility. Dashboards and search tools give staff and managers a real-time view of the tissue inventory — what samples are in stock, where they are stored, their status, and their expiry dates. This visibility supports better decision-making and reduces the risk of samples being overlooked or wasted.
Scalability. An electronic system can handle growth in sample volume, additional storage locations, new users, and expanded workflows without the increasing administrative burden that accompanies paper-based scaling.
Despite the clear benefits, tissue establishments often face real barriers to adoption. Understanding and addressing these barriers is essential for a successful transition.
Cost. Budget is frequently cited as the primary barrier, particularly for smaller research groups and NHS departments. However, the total cost of ownership should be compared against the hidden costs of paper-based systems — staff time spent on manual record keeping, the risk of regulatory non-compliance, and the potential cost of lost or untraceable samples. Many electronic systems offer flexible licensing models, including per-user pricing and cloud-hosted options that reduce upfront infrastructure costs.
Staff resistance. Change is uncomfortable, and staff who have used paper-based methods for years may be reluctant to adopt a new system. The most effective way to address this is through comprehensive training, involvement of key staff in the selection and configuration process, and a phased implementation that allows users to build confidence gradually. Importantly, the system must be intuitive enough that users can return to it after a period of absence and pick up where they left off without extensive retraining.
Data migration. Establishments with existing paper or spreadsheet records face the question of whether to migrate historical data into the new system. This decision depends on the volume and quality of existing data, the regulatory requirement to maintain historical traceability, and the practical feasibility of data entry. In many cases, a pragmatic approach is to enter current inventory into the new system and maintain historical paper records in parallel for reference.
IT infrastructure. Some tissue establishments — particularly those in older hospital buildings or university departments — may have limited IT infrastructure. Cloud-hosted systems can address this by removing the need for on-site servers, while web-based interfaces mean that any device with a modern browser can access the system.
Based on the experiences of tissue establishments that have successfully made the move, several factors consistently contribute to a smooth transition.
The system should be configurable to match the establishment's actual workflows and storage infrastructure. A system that forces the establishment to change its processes to fit the software will face resistance and may introduce new errors. The best outcomes occur when the software is profiled to reflect the establishment's real-world freezer structures, room layouts, and processing steps.
Training should be thorough but practical. Staff should be trained on the specific tasks they will perform, in the environment where they will perform them — not in a generic classroom setting. Ongoing support from the vendor, through telephone, email, and on-site assistance, is essential during the first weeks and months of operation.
The implementation should be phased where possible. Starting with the current inventory and current workflows, and adding historical data or additional features over time, reduces the risk of being overwhelmed and allows the team to build competence and confidence before taking on more complex tasks.
Finally, management support is critical. The decision to move to an electronic system needs visible backing from the tissue bank manager, quality officer, or departmental head. This signals to the team that the transition is a priority and that the investment in training time and workflow adjustment is valued.
The transition from paper to electronic traceability is not without effort, but the benefits — in regulatory compliance, operational efficiency, error reduction, and long-term data security — are substantial and well-evidenced. For tissue banks and tissue establishments that are still relying on paper logbooks, laboratory notebooks, or spreadsheets, the question is increasingly not whether to make the move, but when.
The most successful transitions are those where the system is chosen to fit the establishment's workflows, staff are trained and supported, and the implementation is phased to build confidence over time. With the right approach, the move from paper to electronic can transform a tissue bank's traceability capability — and fundamentally change its relationship with regulatory compliance from one of anxiety to one of confidence.
